Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Eton, Fujifilm, Humacyte, Immunitybio, Jiangsu Hengrui, Johnson & Johnson, Norgine, Novaliq, Novartis, Zyversa.